MxA and CRP-Guided Use of Antimicrobial Agents for AECOPD

NANot yet recruitingINTERVENTIONAL
Enrollment

458

Participants

Timeline

Start Date

January 13, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Acute Exacerbation Chronic Obstructive Pulmonary Disease
Interventions
OTHER

MxA and CRP tests

A whole blood sample will be collected on the day of randomization for MxA and CRP testing.

OTHER

MxA and CRP feedback

MxA and CRP results will be reported to the attending physcian within 4 hours, along with antimicrobial treatment guidelines based on these results.

OTHER

Follow up

"Telephone visit will be conducted on Day 14, Day 30, and Day 90 after randomization.~Day 14 and Day 30 follow-up: antimicrobial usage; additional medical visits, hospitalization, death, symptom scores (CAT score and mMRC score).~Day 90 follow-up: Occurrence of another exacerbation of COPD, symptom scores (CAT score and mMRC score), death."

Trial Locations (1)

100029

China-Japan Friendship hospital, Beijing

All Listed Sponsors
lead

Capital Medical University

OTHER